Novo Nordisk reported 5.96 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 5.96 6.00 4.49 Aug/06 2025
FY2025Q1 Mar/2025 6.53 6.35 5.68 May/07 2025
FY2024Q4 Dec/2024 6.34 6.21 4.91 Feb/05 2025
FY2024Q3 Sep/2024 6.12 6.00 5 Nov/06 2024
FY2024Q2 Jun/2024 4.49 4.48 4.32 Aug/07 2024
FY2024Q1 Mar/2024 5.68 5.68 4.39 May/02 2024


Eps Change Date
Bausch Health Companies USD 1.05 0.37 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
GlaxoSmithKline GBP 0.47 0.02 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Novo Nordisk 5.96 0.57 Jun/2025
Novo Nordisk DKK 12.49 5.96 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
Sanofi EUR 1.59 0.21 Jun/2025
Supernus Pharmaceuticals USD 0.4 0.61 Jun/2025